Status:
UNKNOWN
Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients
Lead Sponsor:
Mattu University
Conditions:
Depression
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Cognitive behavioral therapy ...
Detailed Description
Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Poor adherence decreases the ...
Eligibility Criteria
Inclusion
- PLWHA who were 18 years old and above were included in the study
Exclusion
- PLWHA who were previously took CBT and participants with acute physical or mental disturbances were excluded.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2023
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06109610
Start Date
May 1 2021
End Date
November 1 2023
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mattu University
Addis Ababa, Ethiopia, 318